SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 455 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,549,000 | +60.1% | 450,000 | +51.3% | 2.20% | +84.6% |
| Q2 2023 | $34,069,700 | -40.6% | 297,500 | -28.5% | 1.19% | -37.5% |
| Q1 2023 | $57,337,280 | -58.1% | 416,000 | -60.6% | 1.90% | -35.8% |
| Q4 2022 | $136,706,900 | +30.4% | 1,055,000 | +11.3% | 2.96% | +39.0% |
| Q3 2022 | $104,814,000 | +182.8% | 948,200 | +336.2% | 2.13% | +77.1% |
| Q4 2020 | $37,065,000 | +373.6% | 217,400 | +171.8% | 1.20% | +11.2% |
| Q1 2020 | $7,826,000 | – | 80,000 | – | 1.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |